Liposome Sialidation

Period of Performance: 01/01/1989 - 12/31/1989

$250K

Phase 2 SBIR

Recipient Firm

Siagenic, Inc.
1810 Magnavox Wy
Fort Wayne, IN 46804
Principal Investigator

Abstract

IN PHASE II MODEL COMPOUNDS WILL BE DEVELOPED FOR ECONOMICAL PRODUCTION OF NONPYROGENIC, CLEARANCE-RESISTANT-LIPOSOMES CONTAINING HEMOGLOBIN THAT ARE BOTH INVISIBLE TO IMMUNE SURVEILLANCE AND THAT RETAIN FULL OXYGEN-CARRYING CAPACITY.